CNSA 20th Annual Congress |15-17 June 2016 | Adelaide Convention Centre | Evolving cancer care: enhancing quality | embracing innovation


You are invited to tour SAHMRI (South Australian Health and Medical Research Institute) 

CNSA have arranged two private tours of SAHMRI, to be held prior to the commencement of the CNSA Congress.  The tours will be hosted by a nominated researcher from SAHMRI.

When you join the CNSA private tours of SAHMRI, you will:

  • View a stunning state of the art facility with well recognised architecture
  • Gain a deeper understanding of why medical research plays such a vital role in our community
  • Understand why SAHMRI as an organisation is so unique

Tour times are as follows:

Wednesday 14th June

Tour One         2.15pm to 3.00pm

Tour Two         3.30pm to 4.15pm

There is a maximum of 20* participants per tour.

Spaces on these tours can be reserved during the registration process, on a first come, first served basis.

More about SAHMRI

The SAHMRI vision is to transform research into health, providing:

  • a vibrant, globally-recognised institute that fosters discovery and harnesses dynamic collaborations to deliver health outcomes and community impact 
  • improvements to the quality of life for all people, through innovative, world-class and ground-breaking health and medical research 
  • a clear focal point for health and medical research in South Australia

SAHMRI's cancer research focuses on:

  • acute lymphoblastic leukaemia (ALL)
  • chronic myeloid leukaemia (CML)
  • myeloma
  • prostate cancer
  • gastrointestinal cancers including bowel cancer

With a strong focus on translating scientific discoveries into better outcomes for patients, a number of SAHMRI’s cancer researchers are also clinicians.   Lead by Professor Timothy Hughes, the cancer team works across the entire research spectrum, from fundamental genomic discovery, to developmental biology, translational research and the development of innovative clinical trials. Their goal is to make a difference to cancer patients and their outcomes.

For more information about SAHMRI, please visit